Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 182
News
News | 16 May 2021

Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr

Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021

News
News | 16 May 2021

Cadila Healthcare divests animal health business: ICICI Securities

The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.

News
News | 16 May 2021

Govt. to augment Covaxin production by 10 crore doses

Financial support is being provided as a grant from the Government of India

News
News | 15 May 2021

SPARC announces positive results from Phase 3 trial of PDP-716

The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day

News
News | 15 May 2021

Alembic gets USFDA approval for Lurasidone Hydrochloride tablets

Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder

News
News | 15 May 2021

Dr. Reddy's Sputnik V India price is Rs. 995.40

The company is working closely with its six manufacturing partners in India

News
News | 15 May 2021

Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021

News
News | 15 May 2021

Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr

The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021

News
News | 15 May 2021

Granules to donate 16 crores Paracetamol tablets to Telangana

The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months

News
News | 14 May 2021

Gap between two doses of Covishield extended; No extension for Covaxin

The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield

News
News | 14 May 2021

Govt. to allow 100% doses of imported and ready to use foreign vaccine

Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India

News
News | 13 May 2021

Zydus Cadila entity to sell its India focused animal health business to a consortium

The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,

News
News | 13 May 2021

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021

News
News | 13 May 2021

COVAXIN phase II/III clinical trial approved for 2-18 years

BBIL had proposed to carry out Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years

News
News | 13 May 2021

Torrent Pharma enters into agreement with Lilly for Baricitinib for Covid-19 in India

The agreement will help ensure wider reach and access to patients in India

News
News | 13 May 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021

News
News | 12 May 2021

Additional Tocilizumab allocated to states: Gowda

The additional allocation of Tocilizumab will ensure sufficient availability for COVID-19 patients and augment the government’s efforts to fight the pandemic

News
News | 12 May 2021

Dr. Reddy's launches Ertapenem in US

The INVANZ brand and generic market had U.S. sales of approximately US $205 million MAT for the most recent twelve months ending March 2021 according to IQVIA Health

News
News | 12 May 2021

Govt. ramps up Amphotericin B manufacturing to fight Mucormycosis

The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021

News
News | 12 May 2021

Brinton triples production of COVID-19 drug Favipiravir

Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases

Startup

Digitization